Sirius XM (NASDAQ:SIRI): Barrington believes that Sirius XM’s subscriber gains were “exceptionally good,” and the firm thinks the company’s growth momentum remains intact. It keeps an Outperform rating on the shares with a price target of $4.25, up from $3.75.
Intuitive Surgical (NASDAQ:ISRG): Cantor believes Intuitive Surgical’s $500 million accelerated share repurchase program announced Monday should provide near-term stability for shares. The firm says it’s not surprised the board acted quickly to support the stock after the company recently cut its 2013 outlook, and it reiterates a Buy rating on the stock with a $425 price target.
Pfizer Inc. (NYSE:PFE): Leerink believes Pfizer’s plan to separate into three global businesses while integrating emerging markets into each segment is well conceived, and the firm thinks the announcement should please investors. It keeps a Market Perform rating on the stock.
Halliburton Co. (NYSE:HAL): Argus expects investors to focus more on Halliburton’s fundamentals after the company settled criminal charges with the Justice Department, and believes that the stock is very cheap on a historical basis. The firm raises its price target to $53 from $48 and reiterates a Buy rating on the shares.
Don’t Miss: Can Sirius XM Keep This Momentum?